There are many misconceptions about the prevalence and effects of hypoglycemia in people
with type 2 diabetes (T2D), including hypoglycemia does not occur or does not have …

Objective Diabetes is a global public health concern. Management of diabetes depends on
successful implementation of strategies to alleviate decline in executive functions (EFs), a …

Background Recurrent moderate hypoglycemia (RH), a major adverse effect of
hypoglycemic therapy in diabetic patients, is one of the main risk factors for cognitive …

Alzheimer's disease (AD) represents a significant public health concern in modern society.
Metabolic syndrome (MetS), which includes diabetes mellitus (DM) and obesity, represents …

Hypoglycemia is an independent risk factor of cognitive impairment in patients with diabetes.
Our previous study indicated that dysfunction of astrocytic mitochondria induced by recurrent …

The present study aimed to determine the relationship between astrocytes and recurrent non-
severe hypoglycemia (RH) 2-associated cognitive decline in diabetes. RH induced cognitive …

Type 1 diabetes (T1D) presents a persistent medical challenge, demanding innovative
strategies for sustained glycemic control and enhanced patient well-being. Beta cells are …

Background & aims We evaluated the effect of weight loss induced by dietary carbohydrate
restriction on health-related quality of life (HRQoL) and cognition in type 2 diabetes (T2D) …

Background: Excess carbohydrate intake during hypoglycemia can lead to rebound
hyperglycemia (RH). We investigated associations between RH and use of real-time …

Objective Cognitive impairment in type 2 diabetes is associated with cerebral glucose
hypometabolism. Providing a glucose substitute such as ketone bodies might restore …